Blackrock MuniYield Fund Inc Stock News

Bank of America Corp DE raised its holdings in Blackrock Muniyield Fund Inc. (NYSE:MYD) by 6.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commi

Advisor Group Inc. lifted its position in shares of Blackrock Muniyield Fund Inc. (NYSE:MYD) by 31.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 27,671

Blackrock Muniyield Fund Inc. (NYSE:MYD) shot up 5.8% during mid-day trading on Tuesday . The stock traded as high as $11.32 and last traded at $11.22, 252,849 shares traded hands during trading. An i

Companies became cash rich as the financial markets recovered and in 2009, we witnessed a V shaped recovery for US stocks as the crisis

On Thursday morning, 1178 companies hit new 52-week lows. Facts of Interest: The largest company by market cap to set a new 52-week low was Nuveen Preferred & Income...

Citigroup Inc. decreased its position in shares of Blackrock Muniyield Fund Inc. (NYSE:MYD) by 5.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Comm

March 16, 2020 Dear Customer, At Myriad, we are actively monitoring the COVID-19/Coronavirus situation and have implemented a business… | March 17, 2020

Myriad (MYGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Blackrock Muniyield Fund Inc. (NYSE:MYD) announced a monthly dividend on Wednesday, March 4th, Wall Street Journal reports. Shareholders of record on Monday, March 16th will be given a dividend of 0.0

Blackrock Muniyield Fund Inc. (NYSE:MYD) shares hit a new 52-week high during trading on Monday . The stock traded as high as $15.43 and last traded at $15.36, with a volume of 2200 shares traded. The

This study result is a major breakthrough and is expected to strengthen Myriad Genetics' (MYGN) Oncology segment.

With the receipt of the regulatory approval, Myriad Genetics (MYGN) will be taking a major stride forward in its Oncology and Women's Health segment.

LOS ANGELES--(BUSINESS WIRE)---- $MYGN #classaction--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Myriad Genetics, Inc., (“Myriad” or the �